Phase III randomized controlled clinical study of UFT/LV [tegafur/uracil/folinic acid] therapy versus UFT/LV + PSK [polysaccharide-K] therapyfor Histological Stage IIIa and IIIb Colorectal Cancer
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Polysaccharide K (Primary) ; Folinic acid; Tegafur/uracil
- Indications Colorectal cancer
- Focus Therapeutic Use
- 07 Sep 2007 Status changed from initiated to recruiting.
- 10 Aug 2007 New trial record.